SCYNEXIS to participate in upcoming investor conferences
SCYNEXIS, Inc. says it will participate in upcoming investor conferences, according to a company announcement.
JERSEY CITY, N.J., Sept.
01, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc.
NASDAQ:SCYX, a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with significant unmet medical need, today announced that the company will participate in th…